NY attorney general sues Actavis and Forest Labs over Alzheimer's drug

September 16, 2014 1:30 AM

18 0

Sept 15 (Reuters) - The attorney general of New York filed a lawsuit against Actavis Plc and its subsidiary to stop the companies from discontinuing its Alzheimer's drug, alleging that they were trying to maintain a monopoly position illegally.

Eric Schneiderman, New York's attorney general, alleges that Actavis and its subsidiary Forest Laboratories violated anti-trust and state laws.

Also read: Fitbit Employees Charged in Jawbone Trade-Secrets Case

Read more

To category page